PN 78191
RN 00971 
AN 78204217
AU Breslow-J-L.  Epstein-J.  Fontaine-J-H.  Forbes-G-B.
TI Enhanced dexamethasone resistance in cystic fibrosis cells:
   potential use for heterozygote detection and prenatal diagnosis.
SO Science. 1978 Jul 14. 201(4351). P 180-2.
MJ CYSTIC-FIBROSIS: pp.  DEXAMETHASONE: to.
MN AMNIOTIC-FLUID: cy.  CELL-SURVIVAL: de.  CYSTIC-FIBROSIS: di, fg.
   DRUG-RESISTANCE.  FEMALE.  HETEROZYGOTE.  HOMOZYGOTE.  HUMAN.
   PREGNANCY.  PRENATAL-DIAGNOSIS.  SUPPORT-U-S-GOVT-P-H-S.
AB Cultured skin fibroblasts from patients with cystic fibrosis (CF) are
   more resistant to dexamethasone toxicity than are normal cells. We
   now report that, when fibroblasts cultured from obligate CF
   heterozygotes are exposed to dexamethasone, they have an intermediate
   survival compared to normal and homozygous CF cells. When
   dexamethasone survival was tested on cells from four patients
   undergoing amniocentesis, cells from a woman at risk of producing a
   child with CF showed significant dexamethasone resistance, similar to
   that of fibroblasts derived from lnown CF homozygotes; the other
   amniotic cell specimens showed dexamethasone sensitivity similar to
   that of normal skin fibroblasts. These data suggest that the
   dexamethasone resistance previously observed in skin fibroblasts may
   also be useful in the prenatal diagnosis of CF.
RF 001   ANON                  J PEDIATR                       88   711 976
   002   DI SANTAGNESE PA      N ENGL J MED                   295   481 976
   003   EPSTEIN JL            PROC NAT ACAD SCI USA           74  5642 977
   004   EPSTEIN JL            PROC NAT ACAD SCI USA           74  1676 977
   005   BRESLOW JL            CELL                            13   663 978
   006   BRESLOW JL            EXP CELL RES                   110   399 977
   008   FREUND JE             MODERN ELEMENTARY STATISTICS             967
CT   1   HOSLI P               LANCET                           2   543 979
     2   MAHONEY MJ            CLIN PERINATOL                   6   255 979
     3   KURNIT DM             ANNU REV GENET                  13   235 979
     4   HARRIS A              DEVELOP MED CHILD NEUROL        21   675 979
     5   SHWACHMAN H           J PEDIATR                       95   661 979
     6   HOSLI P               FEBS LETTERS                   104   271 979
     7   KURZ JB               SCIENCE                        206  1317 979
     8   SCANLIN TF            CLIN CHEST MED                   1   424 980
     9   DAVIS PB              PEDIATR RES                     14    83 980
    10   TARNOKY AL            J ROY SOC MED                   73    73 980
    11   BARDON A              CLIN CHIM ACTA                 101    17 980
    12   BRESLOW JL            SCIENCE                        207  1007 980
    13   DANIEL A              HUM GENET                       57    96 981
    14   KELLER GH             ARCH BIOCHEM BIOPHYS           211   321 981
    15   BRESLOW JL            N ENGL J MED                   304     1 981
    16   LITTLEFIELD JW        N ENGL J MED                   304    44 981
    17   SEALE TW              ANN CLIN LAB SCI                12   415 982
    18   KHALID BAK            CLIN ENDOCRINOL                 18   407 983
    19   KHALID BAK            MOL CELL ENDOCRINOL             30   303 983
    20   LANGHOFF E            PEDIATR RES                     18   488 984
    21   NELSON MM             S AFR MED J                     66   688 984
    22   GROSS NJ              AM REV RESPIR DIS              129   805 984
    23   BOUE A                PRESSE MED                      14   575 985
    24   POLANSKY J            INVEST OPHTHALMOL VIS SCI       26   805 985
    25   RAVIA Y               HUM GENET                       71   294 985
    26   BOUE A                HUM GENET                       74   288 986
    27   KUZEMKO JA            J ROY SOC MED                   79     2 986